The reversible P2Y12 antagonist cangrelor influences the ability of the active metabolites of clopidogrel and prasugrel to produce irreversible inhibition of platelet functionNatalia Dovlatova, Stan Heptinstall, Joseph A. Jakubowski et al.|Journal of Thrombosis and Haemostasis|2008Cited by 105